Abstract
We have investigated the effects of the truncated trkB receptor isoform T1 (trkB.T1) by transient transfection into mouse N2a neuroblastoma cells. We observed that expression of trkB.T1 leads to a striking change in cell morphology characterized by outgrowth of filopodia and processes. A similar morphological response was also observed in SH-SY5Y human neuroblastoma cells and NIH3T3 fibroblasts transfected with trkB.T1. N2a cells lack endogenous expression of trkB isoforms, but express barely detectable amounts of its ligands, brain-derived neurotrophic factor (BDNF) and neurotrophin-4 (NT-4). The morphological change was ligand-independent, since addition of exogenous BDNF or NT-4 or blockade of endogenous trkB ligands did not influence this response. Filopodia and process outgrowth was significantly suppressed when full-length trkB.TK+ was cotransfected together with trkB.T1 and this inhibitory effect was blocked by tyrosine kinase inhibitor K252a. Transfection of trkB.T1 deletion mutants showed that the morphological response is dependent on the extracellular, but not the intracellular domain of the receptor. Our results suggest a novel ligand-independent role for truncated trkB in the regulation of cellular morphology.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Armanini MP, McMahon SB, Sutherland J, Shelton DL and Phillips HS. . 1995 Eur. J. Neurosci. 7: 1403–1407.
Barbacid M. . 1994 J. Neurobiol. 25: 1386–1403.
Barik S. . 1995 PCR in Neuroscience, Vol. 26: Methods in Neuroscience. Sarkar, G. (ed.). Academic Press: San Diego pp. 309–323.
Baxter GT, Radeke MJ, Kuo RC, Makrides V, Hinkle B, Hoang R, Medina-Selby A, Coit D, Valenzuela P and Feinstein SC. . 1997 J. Neurosci. 17: 2683–2690.
Beck KD, Lamballe F, Klein R, Barbacid M, Schauwecker PE, McNeill TH, Finch CE, Hefti F and Day JR. . 1993 J. Neurosci. 13: 4001–4014.
Berkemeier LR, Winslow JW, Kaplan DR, Nikolics K, Goeddel DV and Rosenthal A. . 1991 Neuron 7: 857–866.
Biffo S, Offenhauser N, Carter BD and Barde YA. . 1995 Development 121: 2461–2470.
Cubitt AB, Heim R, Adams SR, Boyd AE, Gross LA and Tsien RY. . 1995 TIBS 20: 448–455.
Eide FF, Lowenstein DH and Reichardt LF . 1993 Exp. Neurol. 121: 200–214.
Eide FF, Vining ER, Eide BL, Zang K, Wang XY and Reichardt LF . 1996 J. Neurosci. 16: 3123–3129.
Fletcher TL, Cameron P, DeCamilli P and Banker GA . 1991 J. Neurosci. 11: 1617–1627.
Frisén J, Verge VM, Fried K, Risling M, Persson H, Trotter J, Hökfelt T and Lindholm D. . 1993 Proc. Natl. Acad. Sci. USA 90: 4971–4975.
Glass DJ, Nye SH, Hantzopoulos P, Macchi MJ, Squinto SP, Goldfarb M and Yancopoulos GD. . 1991 Cell 66: 405–413.
Hallböök F, Ibáñez CF and Persson H. . 1991 Neuron 6: 845–858.
Hempstead BL, Martin-Zanca D, Kaplan DR, Parada LF and Chao MV. . 1991 Nature 350: 678–683.
Hofer M, Pagliusi SR, Hohn A, Leibrock J and Barde Y-A. . 1990 EMBO J. 9: 2459–2464.
Ip NY, Ibanez CF, Nye SH, McClain J, Jones PF, Gies DR, Belluscio L, LeBeau MM, Espinosa III, R, Squinto SP, Persson H and Yancopoulos GD. . 1992 Proc. Natl. Acad. Sci. USA 89: 3060–3064.
Jing S, Tapley P and Barbacid M. . 1992 Neuron 9: 1067–1079.
Kaplan DR, Hempstead BL, Martin-Zanca D, Chao MV and Parada LF. . 1991a Science 252: 554–558.
Kaplan DR, Martin-Zanca D and Parada LF. . 1991b Nature 350: 158–160.
Kaplan DR, Matsumoto K, Lucarelli E and Thiele CJ. . 1993 Neuron 11: 321–331.
Klein R, Parada LF, Coulier F and Barbacid M. . 1989 EMBO J. 8: 3701–3709.
Klein R, Conway D, Parada LF and Barbacid M. . 1990 Cell 64: 647–656.
Klein R, Jing S, Nanduri V, O'Rouke E and Barbacid M. . 1991a Cell 65: 189–197.
Klein R, Nanduri V, Jing S, Lamballe F, Tapely P, Bryant S, Cordon-Cardo C, Jones KR, Reichardt LF and Barbacid M. . 1991b Cell 66: 395–403.
Klein R, Lamballe F, Bryant S and Barbacid M. . 1992 Neuron 8: 947–956.
Klein R, Smeyne RJ, Wurst W, Long LK, Auerbach BA, Joyner AL and Barbacid M. . (1993) Cell 75: 113–122.
Lamballe F, Klein R and Barbacid M. . 1991 Cell 66: 968–979.
Lewin GR and Barde Y-A. . 1996 Annu. Rev. Neurosci. 19: 289–318.
Lucarelli E, Kaplan D, Matsumoto K, Sickafuse S and Thiele CJ. . 1994 Prog. Clin. Biol. Res. 385: 185–198.
Lucarelli E, Kaplan DR and Thiele CJ. . 1995 J. Biol. Chem. 270: 24725–24731.
Martin-Zanca D, Oskam R, Mitra G, Copeland T and Barbacid M. . 1989 Mol. Cell. Biol. 9: 24–33.
Matsumoto K, Wada RK, Yamashiro JM, Kaplan DR and Thiele CJ. . 1995 Cancer Res. 55: 1798–1806.
Middlemas DS, Lindberg RA and Hunter T. . 1991 Mol. Cell. Biol. 11: 143–153.
Mizushima S and Nagata S. . 1990 Nuc. Acids Res. 18: 5322.
Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB and Brodeur GM. . 1993 N. Engl. J. Med. 328: 847–854.
Nakagawara A, Azar CG, Scavarda NJ and Brodeur GM. . 1994 Mol. Cell. Biol. 14: 759–767.
Ninkina N, Adu J, Fischer A, Piñón LGP, Buchman VL and Davies AM. . 1996 EMBO J. 15: 6385–6393.
Pastor R, Bernal J and Rodriguez PA. . 1994 Oncogene 9: 1081–1089.
Pulido D, Campuzano S, Koda T, Modolell J and Barbacid M. . 1992 EMBO J. 11: 391–404.
Rubio N. . 1997 Eur. J. Neurosci. 9: 1847–1853.
Schneider R and Schweiger M. . 1991 Oncogene 6: 1807–1811.
Seeds NW, Gilman AG, Amano T and Nirenberg MW. . 1970 Proc. Natl. Acad. Sci. USA 66: 160–167.
Shelton DL, Sutherland J, Gripp J, Camerato T, Armanini MP, Phillips HS, Carroll K, Spencer SD and Levinson AD. . 1995 J. Neurosci. 15: 477–491.
Skene JHP, Jacobson RD, Snipes GJ, McGuire CB, Norden JJ and Freeman JA. . 1986 Science 233: 783–785.
Soppet D, Escandon E, Maragos J, Middlemas DS, Reid SW, Blair J, Burton LE, Stanton BR, Kaplan DR, Hunter T, Nikolics K and Parada L.F. . 1991 Cell 65: 895–903.
Squinto SP, Stitt TN, Aldrich TH, Davis S, Bianco SM, Radziejewski C, Furth ME, Valenzuela, DM, DiStefano PS and Yancopolous GD. . 1991 Cell 65: 885–893.
Tannahill L, Klein R and Schachner M. . 1995 Eur. J. Neurosci. 7: 1424–1428.
Toma JG and Kaplan DR. . 1997 Neural Notes 111: 20.
Tsoulfas P, Soppet D, Escandon E, Tessarollo L, Mendoza-Ramirez J-L, Nikolocs ARK and Parada LF. . 1993 Neuron 10: 975–990.
Vaughan III, VC, McKay Jr RJ and Behrman RE. . 1979 Nelson Textbook of Pediatrics. Nelson, W.E. (ed.). W.B. Saunders Company: Philadelphia pp 1444–1447.
Weskamp G and Reichardt LF. . 1991 Neuron 6: 649–663
Yamashiro DJ, Nakagawara A, Ikegaki N, Liu X and Brodeur GM. . 1996 Oncogene 37–41.
Zhou H, Welcher AA and Shooter EM. . 1997 J Neurosci Res 49: 281–291.
Acknowledgements
The authors would like to thank Ms Laila Kukkonen for excellent technical assistance and M.Sc. Nina Honka for the help in cloning the trkB cDNAs. We are grateful to Dr Alexander Parsadanian for generously providing the sequence for mouse NT-4, to Dr Louis Reichardt for the gift of REX antibody, to Dr Shigekazu Nagata for kindly providing the pEF-BOS expression vector, to Chris Burnett (Palo Alto Institute of Molecular Medicine) for the gift of red shift GFP, to Dr Teemu Teeri for providing the red shift GFP construct in pEF-BOS expression plasmid, and to Regeneron Pharmaceuticals for the gift of trkB-IgG. We would also like to thank Drs Heikki Rauvala, Antero Salminen and Ari Huovila for helpful discussions during this study. This study has been supported by the Academy of Finland EU Biotechnology grant (PL 970259), and Sigrid Juselius Foundation. AH and TS are Ph.D. students of the Finnish Graduate School for Neuroscience and A.I. Virtanen Institute Graduate School, respectively.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Haapasalo, A., Saarelainen, T., Moshnyakov, M. et al. Expression of the naturally occurring truncated trkB neurotrophin receptor induces outgrowth of filopodia and processes in neuroblastoma cells. Oncogene 18, 1285–1296 (1999). https://doi.org/10.1038/sj.onc.1202401
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202401
Keywords
This article is cited by
-
A kinase-deficient NTRK2 splice variant predominates in glioma and amplifies several oncogenic signaling pathways
Nature Communications (2020)
-
The roles played by the MYCN, Trk, and ALK genes in neuroblastoma and neural development
Surgery Today (2019)
-
SVCT2 Overexpression in Neuroblastoma Cells Induces Cellular Branching that is Associated with ERK Signaling
Molecular Neurobiology (2016)
-
In Vivo Evidence that Truncated Trkb.T1 Participates in Nociception
Molecular Pain (2009)
-
Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas
Oncogene (2005)